• (PLX AI) – Novo Nordisk third quarter sales increased by 15% and operating profit increased by 19%.
  • • Outlook FY revenue growth 12-15%, up from 10-13% previously
  • • Outlook FY EBIT growth 12-15%, up from 9-12% previously

Quelle: PLX AI